We are live on
!
Find out more
Parnassus Investments Portfolio holdings
AUM
$37.4B
1-Year Est. Return
35.42%
This Fund
S&P 500
This Quarter
Est. Return
+12.51%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$43.4B
AUM Growth
+$1.74B
(+4.2%)
Cap. Flow
-$2.16B
Cap. Flow
% of AUM
-4.99%
Top 10 Holdings %
Top 10 Hldgs %
38.55%
Holding
157
New
22
Increased
31
Reduced
95
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$483M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$311M |
| 3 |
Willis Towers Watson
WTW
|
+$106M |
| 4 |
Alcon
ALC
|
+$82.2M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$56.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$838M |
| 2 |
Microsoft
MSFT
|
+$524M |
| 3 |
Ball Corp
BALL
|
+$195M |
| 4 |
Pfizer
PFE
|
+$112M |
| 5 |
Simon Property Group
SPG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.06% |
| 2 | Financials | 16.65% |
| 3 | Industrials | 12.24% |
| 4 | Healthcare | 11.49% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lam Research
LRCX
$392B
| $70.9M | 0.16% |
728,028
-44,430
| -6% | -$3.52M |
|
77
US Foods
USFD
$23.5B
| $70.1M | 0.16% |
910,863
-69,870
| -7% | -$4.98M |
|
|
NVO
78
Novo Nordisk
NVO
$209B
| $69.8M | 0.16% |
1,011,546
+85,463
| +9% | +$5.81M |
|
79
Old Dominion Freight Line
ODFL
$41.4B
| $67.9M | 0.16% |
418,252
-55,010
| -12% | -$8.78M |
|
80
Hubbell
HUBB
$25B
| $66.8M | 0.15% |
163,487
-10,071
| -6% | -$3.73M |
|
81
Micron Technology
MU
$1.06T
| $66M | 0.15% |
535,860
-442,232
| -45% | -$41.3M |
|
82
W.R. Berkley
WRB
$25.5B
| $65.7M | 0.15% |
894,317
-83,857
| -9% | -$6.01M |
|
83
UnitedHealth
UNH
$360B
| $65.1M | 0.15% |
208,616
-12,180
| -6% | -$4.66M |
|
84
Xylem
XYL
$26.5B
| $64.9M | 0.15% |
501,727
-181,936
| -27% | -$22M |
|
85
Truist Financial
TFC
$61.9B
| $63.5M | 0.15% |
1,476,432
-505,881
| -26% | -$19.8M |
|
86
O'Reilly Automotive
ORLY
$72.4B
| $62.1M | 0.14% |
689,413
-293,597
| -30% | -$26.8M |
|
87
Atlassian
TEAM
$42.6B
| $61.8M | 0.14% |
304,117
+48,767
| +19% | +$10.2M |
|
88
Pool Corp
POOL
$6.85B
| $57.6M | 0.13% |
197,711
-13,524
| -6% | -$4.09M |
|
89
Roper Technologies
ROP
$40.9B
| $55M | 0.13% |
97,083
-7,101
| -7% | -$4.01M |
|
90
Guidewire Software
GWRE
$15.9B
| $54.4M | 0.13% |
231,191
-136,934
| -37% | -$29.4M |
|
|
91
Regeneron Pharmaceuticals
REGN
$83.9B
| $53.1M | 0.12% |
+101,084
| New | +$56.4M |
|
92
CoStar Group
CSGP
$13B
| $52.7M | 0.12% |
+655,398
| New | +$51.1M |
|
93
Vulcan Materials
VMC
$35.5B
| $51.6M | 0.12% |
+197,796
| New | +$50.9M |
|
94
Trade Desk
TTD
$6.12B
| $46.6M | 0.11% |
647,351
-849,445
| -57% | -$54.2M |
|
|
SNDK
95
Sandisk
SNDK
$220B
| $46.2M | 0.11% |
1,019,161
+267,816
| +36% | +$10.2M |
|
96
Allstate
ALL
$66.2B
| $45.7M | 0.11% |
227,045
-193,726
| -46% | -$38.6M |
|
97
Walmart Inc
WMT
$830B
| $45.6M | 0.11% |
+466,056
| New | +$44.4M |
|
98
Pentair
PNR
$10B
| $45.5M | 0.11% |
443,547
-31,286
| -7% | -$2.92M |
|
99
Intel
INTC
$466B
| $43.8M | 0.1% |
1,956,351
+144,227
| +8% | +$2.99M |
|
100
Copart
CPRT
$30.2B
| $43.3M | 0.1% |
881,799
+122,968
| +16% | +$6.88M |
|
Similar funds
ECSS
PIF
TWC
Parnassus Investments's Q2 2025 Portfolio in Review
As of Q2 2025, Parnassus Investments held 157 positions worth $43.4B, up 4.2% from $41.6B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parnassus Investments withdrew a net $2.16B in Q2 2025, closing 9 positions and reducing 95 holdings. Its most notable exit was Pfizer, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
Against the trend, Parnassus Investments opened a new position in Willis Towers Watson worth $105M.
- Parnassus Investments's largest Q2 2025 buy was Willis Towers Watson: 341,414 shares worth $105M.
- Parnassus Investments added most to Danaher in Q2 2025, an estimated $483M increase.
- Parnassus Investments's biggest Q2 2025 reduction was Cigna, cutting an estimated $838M.
- Parnassus Investments fully exited Pfizer in Q2 2025, selling an estimated $112M.
- Parnassus Investments's ten largest holdings make up 39% of its $43.4B portfolio in Q2 2025.
- Parnassus Investments opened 22 new positions and closed 9 in Q2 2025.
- Parnassus Investments's portfolio value rose 4.2% quarter-over-quarter to $43.4B.
Based on Parnassus Investments's 13F filing for Q2 2025, filed 6 Aug 2025.